检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张秋月[1] 杜涌瑞[2] 许静静[1] 谷超[1] 邓为民[1]
机构地区:[1]天津医科大学,天津300070 [2]天津市中心妇产医院
出 处:《山东医药》2012年第6期5-7,共3页Shandong Medical Journal
基 金:国家自然科学基金资助项目(30670801);天津市科学技术委员会基金资助项目(06YFJMJC08300)
摘 要:目的观察抗CD44单克隆抗体(mAb)A3D8对腹水源卵巢癌球形体形成细胞(A-SFC)凋亡的影响,并探讨其机制。方法将常规培养的A-SFC随机分为观察组和对照组,观察组加入A3D8至其终浓度为2 mg/L,对照组不加药。培养24 h后用Annexin V-FITC/PI凋亡检测试剂盒检测细胞凋亡率;用罗丹明123试剂盒测算细胞线粒体膜电位;用Western blot法检测A-SFC细胞中的CDK2、cyclin A、Bcl-2和Caspase-3。结果观察组细胞凋亡率11.62%±1.01%、线粒体膜电位损失率31.32%±3.47%,对照组分别为6.02%±0.79%、17.65%±2.03%,两组细胞凋亡率和线粒体膜电位损失率相比P均<0.05。观察组CDK2、cyclin A、Bcl-2、Caspase-3蛋白相对表达量分别为对照组的79%、64%、95%、160%。结论 A3D8可促进A-SFC凋亡,其机制可能与A3D8下调CDK2、cyclin A、Bcl-2表达,上调Caspase-3蛋白表达,促进线粒体膜电位损失有关。Objective To explore the effects and mechanisms of A3D8(mAb against CD44) on apoptosis in sphere-forming cells from ascites(A-SFC) of ovarian cancer.Methods The routine cultured A-SFC cells were divided into observation and control group,the observation group was put into 2 mg/L A3D8,and control group nothing.After the 24 h cultivation,Annexin V-FITC/PI apoptosis detection kit was used to analyze cell apoptosis.Rhodamine123 apoptosis detection kit was used to detect the change of mitochondrial transmembrane potential(ΔψM).Western blot assay was used to detect the CDK2,cyclin A,Bcl-2 and Caspase-3 protein levels.Results The apoptosis rates of observation group was 11.62%±1.01%,the loss of ΔψM was 31.32%±3.47%,and the control group was 6.02%±0.79%、17.65%±2.03%.Compared to control group,P〈0.05 all.The CDK2,cyclin A,Bcl-2 and Caspase-3 relative protein level in obsenation group was 79%,64%,95%,160% compared with control group(P〈0.05 all).Conclusion A3D8 can cause apoptosis on A-SFC,the probably mechanism maybe that A3D8 reduce CDK2、cyclinA、Bcl-2 level,raise Caspase-3,raise the loss of ΔψM.
关 键 词:A3D8 腹水源卵巢癌球形体形成细胞 细胞凋亡
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.46